OFLAWEL-OZ contains Ofloxacin 200 mg + Ornidazole 500 mg, combining antibacterial and antiprotozoal/anaerobic coverage for selected mixed infections. A broad-utility PCD Pharma Anti-Infective offering.
Selected mixed bacterial/anaerobic and protozoal infections.
No; treatment depends on the cause.
Use strictly as prescribed and complete the course. Avoid alcohol during treatment and for the period advised after Ornidazole therapy. Inform the physician about liver disease or neurological disorders.
Nausea, metallic taste, diarrhea, abdominal discomfort, dizziness and headache may occur.
OFLAWEL-OZ: Ofloxacin inhibits bacterial DNA replication, while Ornidazole damages DNA in susceptible anaerobic organisms and certain protozoa.
